Apr 15, 2024, 01:22
Fuji Fujiwara: Our work dissecting mRNA expression of immune markers is now available!
Fuji Fujiwara, Hematology/Oncology fellow at Roswell Park Comprehensive Cancer Center, shared on X:
“Let me re-post! Our work dissecting mRNA expression of immune markers is now available! High IDO1 expression appears to predict better response to first line immunotherapy in cancer. I appreciate amazing mentorship from Razelle Kurzrock.”
Additional information.
Source: Fuji Fujiwara/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14